Cargando…
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and the Risk of Developing Incidental Tuberculosis: A Population-Based Cohort Study
Background and Objectives: Treatment for antineutrophil cytoplasmic antibody-associated vasculitis (AAV) must deal with immunosuppression, as well as infections associated with a compromised immune system, such as tuberculosis (TB). Our aim was to examine the risk of incidental TB after diagnosis of...
Autores principales: | Chan, Shan-Ho, Li, Ming-Feng, Ou, Shih-Hsiang, Lin, Mei-Chen, Wang, Jen-Hung, Lee, Po-Tsang, Chen, Hsin-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673265/ https://www.ncbi.nlm.nih.gov/pubmed/38003970 http://dx.doi.org/10.3390/medicina59111920 |
Ejemplares similares
-
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review
por: Choi, Chan-Bum, et al.
Publicado: (2019) -
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis
Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015) -
Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017) -
The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019) -
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)